Phase II study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer. [electronic resource]
Producer: 20141118Description: 1699-702 p. digitalISSN:- 2476-762X
- Adult
- Aged
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Chemoradiotherapy
- Combined Modality Therapy
- Disease-Free Survival
- Dose Fractionation, Radiation
- Drug Administration Schedule
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Paclitaxel -- adverse effects
- Radiotherapy, Conformal
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.